title: Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture.
abstract: We previously reported the in vitro differential stereoselective dysmorphogenic potential of the R(+) and S(-) enantiomers of 2n-propyl-4-pentynoic acid (4-yn-VPA) in mice. To determine whether this stereoselectivity is species specific, we evaluated the dysmorphogenic potential of these isomers as well as valproic acid (VPA) to gestational day 9 rat embryos using whole embryo culture (WEC). Aqueous solutions of the sodium salts of R-4-yn-VPA, S-4-yn-VPA, 50%R/ 50%S-4-yn-VPA or VPA were added to the culture medium to give 0, 0.075, 0.15, 0.3, 0.6, or 1.2 mmol/L and embryos were evaluated 48 hr later. The S-4-yn-VPA enantiomer gave clear concentration-dependent dysmorphology as well as effects on developmental score, somite number, crown rump length, and head length. Effects on rotation and defects of the neural tube, somites and heart were observed. Embryolethality was observed only at 1.2 mmol/L concentration. The R-4-yn-VPA enantiomer was neither embryo toxic nor dysmorphogenic at any concentration. VPA significantly reduced all parameters and was dysmorphogenic at the highest concentration but was not embryo lethal. The 50/50 mixture of R- and S-isomers appeared to elicit a degree of embryolethality and dysmorphology similar to VPA. The potency order for the four chemicals was S(-) > S(-)/R(+) = VPA > > > R(+), comparable to that observed in mice by either in vivo or in vitro exposure. These data demonstrate that the stereoselective dysmorphology for these enantiomers can be observed across species and is not related to maternal metabolism.
authors.affiliation: Reproductive Toxicology Division, NHEERL, U.S. EPA, Research Triangle Park, North Carolina 27711, USA.
authors.forename: J E
authors.initials: JE
authors.lastname: Andrews
authors.forename: M T
authors.initials: MT
authors.lastname: Ebron-McCoy
authors.forename: U
authors.initials: U
authors.lastname: Bojic
authors.forename: H
authors.initials: H
authors.lastname: Nau
authors.forename: R J
authors.initials: RJ
authors.lastname: Kavlock
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000196:embryology*; D000818:Animals; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005231:Fatty Acids, Unsaturated / Q000633:toxicity*; D005260:Female; D008297:Male; D051379:Mice; D009924:Organ Culture Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D013045:Species Specificity; D013237:Stereoisomerism; D013723:Teratogens / Q000633:toxicity*; D014635:Valproic Acid / Q000031:analogs & derivatives*
chemical_list: D005231:Fatty Acids, Unsaturated; D013723:Teratogens; C071194:2-n-propyl-4-pentynoic acid; D014635:Valproic Acid